Press-Republican

Local News

February 18, 2009

New company will use Akrimax for pharmaceutical manufacturing

PLATTSBURGH — U.S. Sen. Charles Schumer was in Plattsburgh Wednesday to announce a new pharmaceutical company for which Akrimax Pharmaceuticals will manufacture product in Rouses Point.

Rouses Point Pharmaceuticals LLC is the creation of Akrimax Pharmaceuticals executives Joseph Krivulka and Leonard Mazur.

“The company hopes its first-year sales will be in excess of $20 million,” Schumer said.

He said private-sector jobs are the best way to pump money into the economy.

Rouses Point Pharmaceuticals will market generic products to chain, wholesale and medical customers across the United States.

Schumer said he has long been committed to bringing low-cost pharmaceutical alternatives to the marketplace. He said that market is poised for rapid growth as a number of companies lose patent protection in the coming years.

Akrimax Manufacturing, a division of Akrimax Pharmaceuticals, is the exclusive producer of the new company’s products.

Rouses Point Pharmaceuticals shipped its first product this week. Propranolol-ER is a non-selective beta-blocker used mainly to treat hypertension.

It is a generic form of Inderal, one of the products Wyeth manufactured in Rouses Point.

Rouses Point Pharmaceuticals President Ben Maizel said his goal is for $100 million in growth in the next three years.

Akrimax Pharmaceuticals Chairman Joseph Krivulka said it was amazing how fast Schumer reached out to Pfizer after that company acquired Wyeth, in order to ensure the transition of the Rouses Point facility continues smoothly.

The same thing happened when Akrimax was meeting to obtain funding from GE Capital for expansion and improvements as the current credit crisis hit.

Krivulka said Akrimax is ahead of schedule on its transition into the Rouses Point plant. There are up to 30 projects that could be part of that move.

Akrimax Vice Chairman Leonard Mazur said the announcement is an opportunity to start turning around the economic doom and gloom present throughout the country.

“What we see here today is actually historical,” he said.

It is an unprecedented partnership between politicians, regulators and business people.

“You wouldn’t have seen that five years ago,” Mazur said.

It is the latest is a series of moves that will help preserve the 500 jobs at the Wyeth plant in Rouses Point and could even lead to a larger workforce.

Rouses Point Mayor George Rivers said he hopes the village’s relationship with Akrimax and now Rouses Point Pharmaceuticals lasts as long as or longer than its relationship with Wyeth. He said it’s been a pleasure to work with the Akrimax team.

“Economically, it means that businesses are going to stay in Rouses Point,” he said.



E-mail Dan Heath at:

dheath@pressrepublican.com

Text Only | Photo Reprints
New Today
Local News

Recent Article Comments
Albany Round-up

Photo of the Day
Strange News
Videos: Editor Picks
Denver's Largest-Ever Drug Bust Nets Dozens Marines: No Punishment for Nazi-like Flag Vets Look to Translate Military Skills Into Jobs Expert: Removing LA School's Staff 'Appropriate' Raw Video: School Bus Burst Into Flames LA School Reopens Amid Sex Abuse Scandal $25B Settlement Reached Over Foreclosure Abuses Pentagon: Allow Women Closer to Front Lines Obama Gives Education Waivers to 10 States Giffords Aide to Run for Her Seat LA School in Sex Abuse Scandal Reopens Winter Slamming North Asia, Parts of Europe Syrian Forces Renew Bombardment of Homs States, Banks Reach Foreclosure-abuse Settlement Raw Video: Italy's Mount Etna Bursts Into Life Greeks March; Angry Despite Debt Deal Raw Video: U.S. Pullout Celebration Raw Video: Annual Empire State Building Run-Up Man Killed in Courthouse Shootout Air Force Airlines: Leaders Get Polished Service